No Data
Medicare To Reimburse Guardant Health's Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue
10 Health Care Stocks Whale Activity In Today's Session
CNBC Halftime Report Final Trades: Netflix, Meta Platforms, Vertex Pharmaceuticals, Interactive Brokers Group, Pacer US Cash Cows 100 ETF
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday
Guardant Health Shares Are Trading Higher After the Company Announced the CMS Has Approved Advanced Diagnostic Lab Test Status for Its Shield Blood Test for Colorectal Cancer Screening.